Still´s Disease
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease (NCT07203001) | Novartis Pharmaceuticals | 2025-11-03 |
| Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases (NCT01952275) | University of Zurich | 2014-01-01 |
Track Still´s Disease automatically
Every clearance here is in the API, with alerts when new ones post.